ストックスクリーナーアプリを入手
1.05
5.54%
0.0551
プレマーケット:
1.05
前日終値:
$0.9949
開ける：
$0.99
24時間の取引高:
1.42M
Relative Volume:
3.84
時価総額：
$117.26M
収益：
-
当期純損益:
$-24.89M
株価収益率:
-3.5023
EPS:
-0.2998
ネットキャッシュフロー:
$-17.20M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+4.48%
6か月 パフォーマンス:
-3.67%
1年 パフォーマンス:
-6.25%
1日の値動き範囲:
$0.9718
$1.08
1週間の範囲:
$0.8974
$1.08
52週間の値動き範囲:
$0.7709
$1.59
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
Compare CRDL vs TAK, ZTS, HLN, TEVA, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.05 | 117.26M | 0 | -24.89M | -17.20M | -0.2998 |
TAK
Takeda Pharmaceutical Co Adr
|
18.04 | 56.99B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
115.93 | 48.94B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.30B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.14 | 33.94B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
531.82 | 23.31B | 3.18B | 1.33B | 1.04B | 27.90 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-02 | 開始されました | H.C. Wainwright | Buy |
| 2025-01-28 | 開始されました | Rodman & Renshaw | Buy |
| 2024-06-26 | 開始されました | ROTH MKM | Buy |
| 2024-04-22 | 開始されました | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc (CRDL) 最新ニュース
Cardiol Therapeutics (CRDL) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Cardiol Therapeutics (TSX:CRDL) Expands Research Scope In Tsx Small Cap Index - Kalkine Media
If You Invested $1,000 in Cardiol Therapeu (CRDL) - Stock Titan
Cardiol Therapeutics (TSE:CRDL) Shares Down 1.5%Time to Sell? - MarketBeat
CRDL SEC FilingsCardiol Therapeu 10-K, 10-Q, 8-K Forms - Stock Titan
Cizzle Brands Corporation Releases Fiscal Q2 2026 Results - Investing News Network
HC Wainwright & Co. Reiterates Cardiol Therapeutics (CRDL) Buy Recommendation - MSN
(CRDL) Trading Advice (CRDL:CA) - Stock Traders Daily
CRDL Stock Price, Quote & Chart | CARDIOL THERAPEUTICS INC-A (NASDAQ:CRDL) - ChartMill
(CRDL) Optimized Trading Opportunities (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics Touts Phase III MAVERIC Timeline for CardiolRx at TD Cowen Healthcare Conference - MarketBeat
(CRDL) Stock Evaluation Report (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics (CRDL) Stock Analysis Report | Financials & Insights - Benzinga Japan
CRDL: Pivotal phase 3 data for CardiolRx in pericarditis expected late 2024, supporting broad expansion - TradingView
Cardiol Therapeutics (NASDAQ:CRDL) Shares Down 1%What's Next? - MarketBeat
(CRDL) Investment Performance Report (CRDL:CA)Stock Traders Daily Canada - Stock Traders Daily
Immix Biopharma to Participate in Upcoming Investor Conferences - Investing News Network
Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards? - The Globe and Mail
Aug Highlights: Should you avoid Cardiol Therapeutics Inc stock right nowPortfolio Performance Report & High Accuracy Swing Entry Alerts - baoquankhu1.vn
(CRDL) Market Insights and Trading Signals (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics (TSE:CRDL) Trading Down 4.8%Time to Sell? - MarketBeat
Cardiol Therapeutics to Present Cardiovascular Pipeline Update at TD Cowen Health Care Conference - TipRanks
Cardiol Therapeutics (NASDAQ: CRDL) outlines heart programs at TD Cowen - Stock Titan
Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference - TMX Newsfile
Heart disease-focused Cardiol to present at TD Cowen conference - Stock Titan
Objective long/short (CRDL) Report (CRDL:CA) - Stock Traders Daily
argenx to Present at TD Cowen 46th Annual Healthcare Conference - Investing News Network
Should I trade or invest in Cardiol Therapeutics Inc.Market Activity Summary & High Conviction Trade Alerts - mfd.ru
CRDLCardiol Therapeu Latest Stock News & Market Updates - Stock Titan
(CRDL) Trading Performance and Risk Management (CRDL:CA)Stock Traders Daily Canada - Stock Traders Daily
Is Cardiol Therapeutics Inc. (CT9) stock a contrarian opportunityWeekly Trade Summary & Long-Term Safe Investment Ideas - mfd.ru
Moderna to Present at Upcoming Conferences in March 2026 - Investing News Network
Learn to Evaluate (CRDL) using the Charts (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics announces $13.5M bought-deal private placement - MSN
Trend Report: Is Cardiol Therapeutics Inc a cyclical or defensive stockExit Point & Reliable Price Breakout Signals - baoquankhu1.vn
(CRDL) Trading Signals (CRDL:CA) - Stock Traders Daily
Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026 - Investing News Network
Aug Drivers: Is Cardiol Therapeutics Inc stock risky to hold nowRecession Risk & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Why Cardiol Therapeutics Inc. stock remains resilientWeekly Investment Summary & AI Driven Stock Price Forecasts - mfd.ru
Is Cardiol Therapeutics Inc. a momentum stockWeekly Profit Report & Safe Capital Growth Plans - mfd.ru
(CRDL) Financial Trading Report (CRDL:CA) - Stock Traders Daily
Published on: 2026-02-16 14:51:25 - baoquankhu1.vn
Can Cardiol Therapeutics Inc generate free cash flow2025 Price Action Summary & Daily Stock Trend Watchlist - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Cardiol Therapeutics (CRDL) and Centene (CNC) - The Globe and Mail
Cardiol Therapeutics publishes phase II myocarditis study results By Investing.com - Investing.com Nigeria
CRDL Stock Rating Reiterated at 'Buy' by HC Wainwright & Co. | C - GuruFocus
Cardiol Therapeutics (NASDAQ:CRDL) Receives "Buy" Rating from HC Wainwright - MarketBeat
Cardiol Therapeutics Inc. - Baystreet.ca
Cardiol Therapeutics publishes phase II myocarditis study results - Investing.com
Cardiol Therapeutics’ ARCHER Phase II Myocarditis Data Published in ESC Heart Failure - TipRanks
Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure - Investing News Network
Cardiol Therapeutics Inc (CRDL) 財務データ
収益
当期純利益
現金流量
EPS
1.75%
1.88%
大文字化:
|
ボリューム (24 時間):